# Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism

Study · id `cardio:ct-nct05493163` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05493163](<https://clinicaltrials.gov/study/NCT05493163>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05493163

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 558 participants.

## Technical summary

Registry record NCT05493163. Randomized; no masking; primary purpose treatment. Start 2022-10-19 (actual); primary completion 2026-03-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 558 participants (enrolled count; ClinicalTrials.gov record NCT05493163, source copy `cardio:ctgov-nct05493163-2026-11-06`, retrieved 2026-11-18)
- Started: 2022-10-19 (actual) (ClinicalTrials.gov record NCT05493163, source copy `cardio:ctgov-nct05493163-2026-11-06`, retrieved 2026-11-18)
- Primary completion: 2026-03-30 (actual) (ClinicalTrials.gov record NCT05493163, source copy `cardio:ctgov-nct05493163-2026-11-06`, retrieved 2026-11-18)
- Completion: 2026-03-30 (actual) (ClinicalTrials.gov record NCT05493163, source copy `cardio:ctgov-nct05493163-2026-11-06`, retrieved 2026-11-18)
- Countries: Czechia (ClinicalTrials.gov record NCT05493163, source copy `cardio:ctgov-nct05493163-2026-11-06`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05493163-2026-11-06`, retrieved 2026-11-18)

## The registry's words

- Brief title: Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism
- Acronym: PRAGUE-26
- Condition: Pulmonary Embolism
- Intervention (Drug): Thrombolytic
- Intervention (Drug): Standard anticoagulation
- Lead sponsor: Faculty Hospital Kralovske Vinohrady
- Lead sponsor class: OTHER\_GOV
- Collaborator: Charles University, Czech Republic
- Collaborator class: OTHER
- Collaborator: University Hospital Ostrava
- Collaborator class: OTHER
- Collaborator: University Hospital Olomouc
- Collaborator class: OTHER
- Collaborator: Brno University Hospital
- Collaborator class: OTHER
- Collaborator: St. Anne's University Hospital Brno, Czech Republic
- Collaborator class: OTHER
- Collaborator: General University Hospital, Prague
- Collaborator class: OTHER
- Collaborator: University Hospital Pilsen
- Collaborator class: OTHER
- Collaborator: University Hospital Hradec Kralove
- Collaborator class: OTHER
- Collaborator: University Hospital, Motol
- Collaborator class: OTHER
- Collaborator: Hospital Pardubice
- Collaborator class: OTHER
- Collaborator: Tomas Bata Hospital, Czech Republic
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Fibrinolytic (clot-dissolving) drugs (`cardio:fibrinolytic-clot-dissolving-drugs`)
- Registry lists this organization as the lead sponsor: Faculty Hospital Kralovske Vinohrady (`cardio:org-faculty-hospital-kralovske-vinohrady`)
- Registry lists this organization as a collaborator: Charles University, Czech Republic (`cardio:org-charles-university-czech-republic`)
- Registry lists this organization as a collaborator: University Hospital Ostrava (`cardio:org-university-hospital-ostrava`)
- Registry lists this organization as a collaborator: University Hospital Olomouc (`cardio:org-university-hospital-olomouc`)
- Registry lists this organization as a collaborator: Brno University Hospital (`cardio:org-brno-university-hospital`)
- Registry lists this organization as a collaborator: St. Anne's University Hospital Brno, Czech Republic (`cardio:org-st-anne-s-university-hospital-brno-czech-republic`)
- Registry lists this organization as a collaborator: General University Hospital, Prague (`cardio:org-general-university-hospital-prague`)
- Registry lists this organization as a collaborator: University Hospital Pilsen (`cardio:org-university-hospital-pilsen`)
- Registry lists this organization as a collaborator: University Hospital Hradec Kralove (`cardio:org-university-hospital-hradec-kralove`)
- Registry lists this organization as a collaborator: University Hospital, Motol (`cardio:org-university-hospital-motol`)

## Provenance

Content hash: a58d8b5778a013464311b1fd573a159739e58e0a85ed051bad9d9b14a64c92f7
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
